NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Wemedoo AG

Wemedoo AG

Private
SteinhausenEnterprise Softwarehttps://wemedoo.com/

Last Round

Seed

Oct 8, 2024

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Wemedoo AG is a healthcare technology company that provides a unified clinical trial software platform intended to support faster, compliant, and more efficient clinical research operations.

Sector

Enterprise Software

Verticals

Clinical Trials, Vertical SaaS, Workflow Automation, Healthcare Analytics, Medical AI

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting, Freemium

AI Layer

Application

Keywords

unified clinical trial platformeClinical solutionsclinical trial managementdecentralized clinical trialsDCT platformEDCCTMSeTMFclinical trial AIePROrisk-based monitoringRTSMeConsentclinical data managementbiostatistics services

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Wemedoo AG Comps

Public and private peers based on sector, stage, and business model.

Wemedoo AG comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Wemedoo AG Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedOct 8, 2024

Key People

Founding team and executive leadership

Nina Cihoric

Chief Executive Officer

Executive Team

Valérie Czaya

Chief Operating Officer

Executive Team

Wemedoo AG Investors

Notable investors and investment history

Wemedoo AG investors
InvestorRounds
DayOneSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 24, 2026

    Monthly visitors increased 719% MoM.

  • Dec 7, 2025

    Monthly visitors increased 77% MoM to 20.4K.

Wemedoo AG Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Wemedoo AG Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Wemedoo AG's valuation, stock price, and market status.

Firmographic Details

HeadquartersSteinhausen
Employee Range37
Year Founded2020
Last FundingOct 8, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.